CREB1 and non-small cell lung carcinoma: In this study, we demonstrated that the inhibition of PKA/CREB1 pathway increased the susceptibility of NSCLC cells to ferroptosis, suggesting that targeting this pathway may be a novel strategy for the treatment of NSCLC patients.